These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 25793627)

  • 1. Cholesterol Gallstones Larger Than 3 cm Appear to Be Associated With Gallbladder Cancer: Identification of a High Risk Group of Patients That Could Benefit From Preventive Cholecystectomy.
    Andrea C; Enzo A
    Ann Surg; 2016 Mar; 263(3):e56. PubMed ID: 25793627
    [No Abstract]   [Full Text] [Related]  

  • 2. Could Type and Size of Gallstones Influence Gallbladder Carcinogenesis?
    Jain K; Garg PK
    Ann Surg; 2016 Mar; 263(3):e57. PubMed ID: 25575261
    [No Abstract]   [Full Text] [Related]  

  • 3. Sequential occurrence of preneoplastic lesions and accumulation of loss of heterozygosity in patients with gallbladder stones suggest causal association with gallbladder cancer.
    Jain K; Mohapatra T; Das P; Misra MC; Gupta SD; Ghosh M; Kabra M; Bansal VK; Kumar S; Sreenivas V; Garg PK
    Ann Surg; 2014 Dec; 260(6):1073-80. PubMed ID: 24827397
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TP53 abnormalities are frequent and early events in the sequential pathogenesis of gallbladder carcinoma.
    Moreno M; Pimentel F; Gazdar AF; Wistuba II; Miquel JF
    Ann Hepatol; 2005; 4(3):192-9. PubMed ID: 16177659
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cholesterol gallstones and cancer of gallbladder (CAGB): molecular links.
    Venniyoor A
    Med Hypotheses; 2008; 70(3):646-53. PubMed ID: 17855001
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gallbladder cancers: associated conditions, histological types, prognosis, and prevention.
    Cariati A; Piromalli E; Cetta F
    Eur J Gastroenterol Hepatol; 2014 May; 26(5):562-9. PubMed ID: 24614695
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dysfunction of subtelomeric methylation and telomere length in gallstone disease and gallbladder cancer patients of North Central India.
    Poojary SS; Mishra G; Gupta S; Shrivastav BR; Tiwari PK
    J Hepatobiliary Pancreat Sci; 2016 May; 23(5):276-82. PubMed ID: 26856965
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fragile histidine triad gene abnormalities in the pathogenesis of gallbladder carcinoma.
    Wistuba II; Ashfaq R; Maitra A; Alvarez H; Riquelme E; Gazdar AF
    Am J Pathol; 2002 Jun; 160(6):2073-9. PubMed ID: 12057912
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The value of p53 protein expression in gallbladder carcinoma: analysis of 60 cases.
    da Rocha AO; Coutinho LM; Scholl JG; Leboutte LD
    Hepatogastroenterology; 2004; 51(59):1310-4. PubMed ID: 15362740
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epigenetic profiling of gallbladder cancer and gall stone diseases: Evaluation of role of tumour associated genes.
    Singh TD; Gupta S; Shrivastav BR; Tiwari PK
    Gene; 2016 Feb; 576(2 Pt 2):743-52. PubMed ID: 26456195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Global methylation profiling to identify epigenetic signature of gallbladder cancer and gallstone disease.
    Sharma P; Bhunia S; Poojary SS; Tekcham DS; Barbhuiya MA; Gupta S; Shrivastav BR; Tiwari PK
    Tumour Biol; 2016 Nov; 37(11):14687-14699. PubMed ID: 27623942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primary gallbladder cancer: recognition of risk factors and the role of prophylactic cholecystectomy.
    Sheth S; Bedford A; Chopra S
    Am J Gastroenterol; 2000 Jun; 95(6):1402-10. PubMed ID: 10894571
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic alterations in gallbladder carcinoma.
    Kuroki T; Tajima Y; Matsuo K; Kanematsu T
    Surg Today; 2005; 35(2):101-5. PubMed ID: 15674488
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Intraepithelial neoplasia of gall bladder].
    Teng XD; Lai MD
    Zhonghua Bing Li Xue Za Zhi; 2009 Nov; 38(11):781-4. PubMed ID: 20079024
    [No Abstract]   [Full Text] [Related]  

  • 15. Cholelithiasis in gallbladder cancer: coincidence, cofactor, or cause!
    Shrikhande SV; Barreto SG; Singh S; Udwadia TE; Agarwal AK
    Eur J Surg Oncol; 2010 Jun; 36(6):514-9. PubMed ID: 20537839
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic aberrations in gallbladder cancer.
    Maurya SK; Tewari M; Mishra RR; Shukla HS
    Surg Oncol; 2012 Mar; 21(1):37-43. PubMed ID: 20880699
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gallbladder polyps: how to pick up the sinister ones.
    Dutta U; Poornachandra KS
    J Gastroenterol Hepatol; 2009 Feb; 24(2):175-8. PubMed ID: 19215328
    [No Abstract]   [Full Text] [Related]  

  • 18. PSCA gene variants (rs2294008 and rs2978974) confer increased susceptibility of gallbladder carcinoma in females.
    Rai R; Sharma KL; Misra S; Kumar A; Mittal B
    Gene; 2013 Nov; 530(2):172-7. PubMed ID: 23988503
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contribution of silent gallstones in gallbladder cancer.
    Tewari M
    J Surg Oncol; 2006 Jun; 93(8):629-32. PubMed ID: 16724346
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cholecystokinin receptor A gene polymorphism in gallstone disease and gallbladder cancer.
    Srivastava A; Pandey SN; Dixit M; Choudhuri G; Mittal B
    J Gastroenterol Hepatol; 2008 Jun; 23(6):970-5. PubMed ID: 17944886
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.